Riyadh – Mubasher: Dallah Healthcare Company registered net profits amounting to SAR 436.09 million for the third quarter (Q3) of 2026, an annual leap of 207.32% from SAR 141.90 million.
The company attributed the record performance primarily to a one-time gain of SAR 356.60 million from the divestment of its investment in Mohammed Rashid Al Faqih Hospital.
Quarterly revenue rose by 2.31% to SAR 1.09 billion, supported by a 7% increase in patient visits, which reached 1.04 million.
Growth was particularly strong in the Eastern Region, where visits climbed by 20.40%. However, the group noted that infrastructure work surrounding Kingdom Hospital led to a 9% decline in visitors at that facility.
In the first nine months (9M) of 2026, net profit reached SAR 620.62 million, up 47.16% from SAR 421.72 million in 9M-25.
Total revenue for the first three quarters grew by 8.47% to SAR 3.21 billion. Earnings per share (EPS) rose to SAR 5.13 from SAR 3.51 a year earlier.
Total shareholders' equity was reported at SAR 4.49 billion, a 6.32% increase year-on-year (YoY). Excluding non-recurring items, the nine-month net profit would have decreased by 12.8% to SAR 276.40 million.
In the first half (H1) of 2026, the company’s net profit dropped by 34.05% to SAR 184.53 million from SAR 279.82 million in H1-25.
